Diana Tran

Title: Diana Tran: Innovator in Amyloid Beta Detection

Introduction

Diana Tran is a prominent inventor based in Garden Grove, CA (US). She has made significant contributions to the field of biomedical research, particularly in the detection of amyloid beta, which is crucial for understanding Alzheimer's disease and dementia. With a total of 2 patents, her work is paving the way for advancements in diagnostic methods.

Latest Patents

Diana's latest patents focus on innovative methods for the detection and quantitation of amyloid beta. One of her key inventions involves using mass spectrometry to detect amyloid beta or its fragments. Additionally, her patents provide methods for determining the ratio of amyloid beta 42 (Aβ42) to amyloid beta 40 (Aβ40). These advancements are essential for the diagnosis and prognosis of Alzheimer's disease and dementia.

Career Highlights

Diana Tran is currently employed at Quest Diagnostics Investments, Inc., where she continues to develop her groundbreaking research. Her work has garnered attention in the scientific community, contributing to a better understanding of neurodegenerative diseases.

Collaborations

Diana collaborates with esteemed colleagues, including Darren J Weber and Nigel J Clarke. Their combined expertise enhances the research and development of innovative diagnostic methods.

Conclusion

Diana Tran's contributions to amyloid beta detection represent a significant advancement in the field of biomedical research. Her innovative patents and collaborative efforts are vital for improving diagnostic techniques for Alzheimer's disease and dementia.